title: Statins: is it really time to reassess benefits and risks?
authors.affiliation: Harvard Medical School and the Section of Clinical, Behavioral, and Outcomes Research, Joslin Diabetes Center, Boston, USA.
authors.forename: Allison B
authors.initials: AB
authors.lastname: Goldfine
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000139:chemically induced*; D005260:Female; D006442:Glycated Hemoglobin; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006943:Hyperglycemia / Q000139:chemically induced; D008297:Male; D018570:Risk Assessment
chemical_list: D006442:Glycated Hemoglobin; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors